4-[(Aminocarbonyl)amino]benzoic acid

Catalog No.: 
ACYNEP679
CAS No.: 
6306-25-8
Molecular Formula: 
C8H8N2O3
Molecular Weight: 
180.16
4-[(Aminocarbonyl)amino]benzoic acid structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg96%$61.00In stockIn stock
250mg96%$139.00In stockIn stock
1g96%$245.00In stockIn stock
5g96%$1188.00In stockInquiry
25g96%$4564.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name4-[(Aminocarbonyl)amino]benzoic acid
IUPAC Name4-ureidobenzoic acid
MDL No.MFCD00025432
Molecular FormulaC8H8N2O3
Molecular Weight180.16
SMILESO=C(O)C1=CC=C(NC(N)=O)C=C1
InChI KeyHOVRQUHNZHBKKJ-UHFFFAOYSA-N
SynonymNsc22974;4-(carbamoylamino)benzoic acid;Benzoic acid, 4-[(aminocarbonyl)amino]-;Nafamostat Impurity 11;4-(3-(4-guanidinobenzoyl)guanidino)benzoic acid 2,2,2-trifluoroacetate;Fampridine Impurity 39
CAS No.6306-25-8

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P305+P351+P338-P330-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACYNEP679 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACNFPB351 route compound structure diagram
    ACNFPB351138-84-1In Stock
  2. Then
  3. ACYNEP679 route product structure diagram
    ACYNEP6796306-25-8In Stock
Inquiry

2. ACYNEP679 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACYNEP679 route product structure diagram
    ACYNEP6796306-25-8In Stock
Inquiry

3. ACYNEP679 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACYNEP679 route product structure diagram
    ACYNEP6796306-25-8In Stock
Inquiry

Comments (0)